Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

ClinicalTrials.gov ID: NCT05904210

Public ClinicalTrials.gov record NCT05904210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 9:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® [Coagulation Factor VIIa (Recombinant) - Jncw] in the USA

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to assess the real-world utilization (effectiveness, safety, tolerability, and modalities of treatment) of SEVENFACT®.

Study identification

NCT ID
NCT05904210
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
17 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2023
Primary completion
May 8, 2024
Completion
May 8, 2024
Last update posted
Jun 24, 2024

2023 – 2024

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Luskin Orthopaedic Institute for Children Los Angeles California 90007
Valley Children's Hospital Madera California 93636
Children's healthcare of Atlanta Atlanta Georgia 30322
Mayo Clinic Rochester Minnesota 55905
SUNY Upstate Medical University, Pediatric Hematology/Oncology Syracuse New York 13210
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
The Gulf States Hemophilia & Thrombophilia Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05904210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2024 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05904210 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →